WASHINGTON (AP) — The House has passed a bill capping the monthly cost of insulin at $35 for insured patients.
Thursday’s vote is part of an election-year push by Democrats for price curbs on prescription drugs at a time of rising inflation.
Experts say the legislation would provide significant relief for privately insured patients with skimpier plans and for Medicare enrollees facing rising out-of-pocket costs for insulin.
Some could save hundreds of dollars annually.
President Joe Biden’s stalled social legislation would do much more, authorizing Medicare to negotiate prices for insulin and other drugs, penalizing pharmaceuticals that raise prices faster than inflation, and limiting costs for Medicare enrollees.